ArticleBlood cancer journal2015

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis.

P Guglielmelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.